Frazier Financial Advisors, LLC Emergent Bio Solutions Inc. Transaction History
Frazier Financial Advisors, LLC
- $129 Billion
- Q3 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 2 shares of EBS stock, worth $23. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 2
-0.0%
Holding current value
$23
Previous $14,000
21.43%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EBS
# of Institutions
151Shares Held
30.4MCall Options Held
137KPut Options Held
706K-
Black Rock Inc. New York, NY3.84MShares$46 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$43.9 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.22MShares$26.6 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.73MShares$20.7 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.24MShares$14.9 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $597M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...